These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 1444296)
1. Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria. Brochu A; Brochu N; Nicas TI; Parr TR; Minnick AA; Dolence EK; McKee JA; Miller MJ; Lavoie MC; Malouin F Antimicrob Agents Chemother; 1992 Oct; 36(10):2166-75. PubMed ID: 1444296 [TBL] [Abstract][Full Text] [Related]
2. Iron transport-mediated antibacterial activity of and development of resistance to hydroxamate and catechol siderophore-carbacephalosporin conjugates. Minnick AA; McKee JA; Dolence EK; Miller MJ Antimicrob Agents Chemother; 1992 Apr; 36(4):840-50. PubMed ID: 1503447 [TBL] [Abstract][Full Text] [Related]
3. Species selectivity of new siderophore-drug conjugates that use specific iron uptake for entry into bacteria. Diarra MS; Lavoie MC; Jacques M; Darwish I; Dolence EK; Dolence JA; Ghosh A; Ghosh M; Miller MJ; Malouin F Antimicrob Agents Chemother; 1996 Nov; 40(11):2610-7. PubMed ID: 8913474 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and siderophore and antibacterial activity of N5-acetyl-N5-hydroxy-L-ornithine-derived siderophore-beta-lactam conjugates: iron-transport-mediated drug delivery. Dolence EK; Minnick AA; Lin CE; Miller MJ; Payne SM J Med Chem; 1991 Mar; 34(3):968-78. PubMed ID: 1825850 [TBL] [Abstract][Full Text] [Related]
5. Selective growth promotion and growth inhibition of gram-negative and gram-positive bacteria by synthetic siderophore-beta-lactam conjugates. Möllmann U; Ghosh A; Dolence EK; Dolence JA; Ghosh M; Miller MJ; Reissbrodt R Biometals; 1998 Jan; 11(1):1-12. PubMed ID: 9450313 [TBL] [Abstract][Full Text] [Related]
6. Growth of Actinobacillus pleuropneumoniae is promoted by exogenous hydroxamate and catechol siderophores. Diarra MS; Dolence JA; Dolence EK; Darwish I; Miller MJ; Malouin F; Jacques M Appl Environ Microbiol; 1996 Mar; 62(3):853-9. PubMed ID: 8975614 [TBL] [Abstract][Full Text] [Related]
7. State of penicillin-binding proteins and requirements for their bactericidal interaction with beta-lactam antibiotics in Serratia marcescens highly resistant to extended-spectrum beta-lactams. Gunkel AG; Hechler U; Martin HH J Gen Microbiol; 1991 Feb; 137(2):243-52. PubMed ID: 2016583 [TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada. Clairoux N; Picard M; Brochu A; Rousseau N; Gourde P; Beauchamp D; Parr TR; Bergeron MG; Malouin F Antimicrob Agents Chemother; 1992 Jul; 36(7):1504-13. PubMed ID: 1510447 [TBL] [Abstract][Full Text] [Related]
9. Effect of beta-lactams on peptidoglycan metabolism of Haemophilus influenzae grown in animals. Rousseau N; Dargis M; Gourde P; Beauchamp D; Malouin F Antimicrob Agents Chemother; 1992 Oct; 36(10):2147-55. PubMed ID: 1444294 [TBL] [Abstract][Full Text] [Related]
10. Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis? Chambers HF; Moreau D; Yajko D; Miick C; Wagner C; Hackbarth C; Kocagöz S; Rosenberg E; Hadley WK; Nikaido H Antimicrob Agents Chemother; 1995 Dec; 39(12):2620-4. PubMed ID: 8592990 [TBL] [Abstract][Full Text] [Related]
11. Interaction of beta-lactam antibiotics with the penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae. Ikeda F; Yokota Y; Ikemoto A; Teratani N; Shimomura K; Kanno H Chemotherapy; 1995; 41(3):159-64. PubMed ID: 7656660 [TBL] [Abstract][Full Text] [Related]
12. Target for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins. Satta G; Cornaglia G; Mazzariol A; Golini G; Valisena S; Fontana R Antimicrob Agents Chemother; 1995 Apr; 39(4):812-8. PubMed ID: 7785976 [TBL] [Abstract][Full Text] [Related]
13. Interactions of Yersinia pestis penicillin-binding proteins with beta-lactam antibiotics. Ferreira RC; Park JT; Camelo D; De Almeida DF; Ferreira LC Antimicrob Agents Chemother; 1995 Aug; 39(8):1853-5. PubMed ID: 7486931 [TBL] [Abstract][Full Text] [Related]
14. The design, synthesis and study of siderophore-antibiotic conjugates. Siderophore mediated drug transport. Miller MJ; McKee JA; Minnick AA; Dolence EK Biol Met; 1991; 4(1):62-9. PubMed ID: 1830210 [TBL] [Abstract][Full Text] [Related]
15. Penicillin-binding proteins in Streptococcus faecalis and S. faecium. Chen HY; Williams JD J Med Microbiol; 1987 Mar; 23(2):141-7. PubMed ID: 3104591 [TBL] [Abstract][Full Text] [Related]
16. Shifting of the penicillin binding proteins that are the target for inhibition by beta-lactams as a likely mechanism of resistance to antibiotics during therapy. Satta G; Canepari P; Maurici R; Pompei R; Marcialis MA Chemioterapia; 1985 Feb; 4(1):113-5. PubMed ID: 3986940 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity and penicillin-binding protein affinity of new cephalosporin derivatives in Staphylococcus aureus and Escherichia coli. Singh MP; Lee YI; Singh R; Micetich RG; Wilkinson BJ J Antimicrob Chemother; 1991 Apr; 27(4):459-68. PubMed ID: 1856125 [TBL] [Abstract][Full Text] [Related]
18. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Nagai K; Davies TA; Jacobs MR; Appelbaum PC Antimicrob Agents Chemother; 2002 May; 46(5):1273-80. PubMed ID: 11959556 [TBL] [Abstract][Full Text] [Related]
19. Quaternary heterocyclylamino beta-lactams. III. The mode of action of L-640,876 and the effect of NaCl on membrane permeability and binding. Koupal LR; Pelak BA; Cassidy PJ; Gadebusch HH J Antibiot (Tokyo); 1983 Jan; 36(1):54-63. PubMed ID: 6381447 [TBL] [Abstract][Full Text] [Related]
20. Role of permeability barriers in resistance to beta-lactam antibiotics. Nikaido H Pharmacol Ther; 1985; 27(2):197-231. PubMed ID: 2412244 [No Abstract] [Full Text] [Related] [Next] [New Search]